Original Article
Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials
Ryan Zarychanski, Alexis F. Turgeon, Lauralyn McIntyre and Dean A. Fergusson
CMAJ September 05, 2007 DOI: https://doi.org/10.1503/cmaj.071055
Ryan Zarychanski
Alexis F. Turgeon
Lauralyn McIntyre
This is a PDF-only article.
In this issue
Article tools
Erythropoietin-receptor agonists in critically ill patients: a meta-analysis of randomized controlled trials
Ryan Zarychanski, Alexis F. Turgeon, Lauralyn McIntyre, Dean A. Fergusson
CMAJ Sep 2007, DOI: 10.1503/cmaj.071055
Jump to section
Related Articles
Cited By...
- Anemia, Bleeding, and Blood Transfusion in the Intensive Care Unit: Causes, Risks, Costs, and New Strategies
- Erythropoietin stimulates spleen BMP4-dependent stress erythropoiesis and partially corrects anemia in a mouse model of generalized inflammation
- Anemia of chronic disease: A harmful disorder or an adaptive, beneficial response?
- Erythropoietic agents for anemia of critical illness
- Corticosteroids and erythropoeitin-receptor agonists
- Blood conservation strategies to reduce the need for red blood cell transfusion in critically ill patients
- L'expansion des indications : medecins, attention
- Indication creep: physician beware
- Erythropoietin use in critically ill patients: forest and trees